We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
5676
CALL
Ametek
AME
$58.4B
$442K ﹤0.01%
6,100
-2,600
-30% -$181K
AWI icon
5677
CALL
Armstrong World Industries
AWI
$7.7B
$442K ﹤0.01%
7,300
-4,400
-38% -$242K
NHC icon
5678
National Healthcare
NHC
$3.5B
$442K ﹤0.01%
7,257
-6,284
-46% -$401K
SNEX icon
5679
StoneX
SNEX
$8.09B
$442K ﹤0.01%
+52,559
New +$432K
TKR icon
5680
CALL
Timken Company
TKR
$9.25B
$442K ﹤0.01%
9,000
+2,800
+45% +$136K
YANG icon
5681
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.1M
$442K ﹤0.01%
373
+252
+208% +$321K
KERX
5682
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$442K ﹤0.01%
+95,000
New +$523K
NYRT
5683
DELISTED
New York REIT, Inc.
NYRT
$441K ﹤0.01%
11,233
-11,797
-51% -$758K
EHC icon
5684
CALL
Encompass Health
EHC
$12.2B
$440K ﹤0.01%
11,187
+502
+5% +$19.1K
IVR icon
5685
PUT
Invesco Mortgage Capital
IVR
$805M
$440K ﹤0.01%
+2,470
New +$436K
PSXP
5686
PUT
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$440K ﹤0.01%
+8,400
New +$418K
CCU icon
5687
Compañía de Cervecerías Unidas
CCU
$2.18B
$439K ﹤0.01%
+14,857
New +$406K
IAT icon
5688
CALL
iShares US Regional Banks ETF
IAT
$693M
$439K ﹤0.01%
8,900
+2,400
+37% +$115K
FOE
5689
DELISTED
Ferro Corporation
FOE
$439K ﹤0.01%
+18,595
New +$440K
TRQ
5690
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
$439K ﹤0.01%
12,800
+4,960
+63% +$156K
ANIP icon
5691
ANI Pharmaceuticals
ANIP
$1.76B
$438K ﹤0.01%
6,794
-1,484
-18% -$92.3K
HRC
5692
PUT
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$438K ﹤0.01%
5,200
+1,800
+53% +$146K
BOKF icon
5693
BOK Financial
BOKF
$8.88B
$437K ﹤0.01%
4,729
-1,428
-23% -$126K
TCPC icon
5694
BlackRock TCP Capital
TCPC
$342M
$437K ﹤0.01%
+28,585
New +$457K
ZEN
5695
PUT
DELISTED
ZENDESK INC
ZEN
$437K ﹤0.01%
12,900
+3,000
+30% +$98.2K
SREV
5696
DELISTED
ServiceSource International, Inc.
SREV
$437K ﹤0.01%
141,541
-10,999
-7% -$35.4K
AMAG
5697
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
$437K ﹤0.01%
33,000
+6,900
+26% +$104K
PGHY icon
5698
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$227M
$436K ﹤0.01%
+18,282
New +$440K
HTB
5699
HomeTrust Bancshares
HTB
$834M
$436K ﹤0.01%
16,937
-1,958
-10% -$51.4K
RAD
5700
CALL
DELISTED
Rite Aid Corporation
RAD
$436K ﹤0.01%
11,055
+2,915
+36% +$104K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.